ArticleEuropean heart journal. Case reports2022

Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via

Taishi Dotare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.